Automatic Calcium Score Assessment from Coronary CTA Shows Potential to Eliminate Need for Separate Scan
By MedImaging International staff writers Posted on 02 Aug 2011 |
Proof-of-concept has been achieved with the first fully automated software that performs calcium scoring directly from a coronary computed tomography angiography (cCTA) study. This technology, the first to show strong correlation with the standard Agatston scoring, has the potential to eliminate the need for a separate calcium score (CS) exam, and thereby reduce costs and decrease patient radiation exposure.
This work in progress is based on Rcadia Medical Imaging (Newton, MA, USA) COR analyzer system technology for fully automatic detection of stenosis in cCTA studies.
CS is an important predictor of coronary artery disease that is typically used by cardiologists. Until recently, a separate calcium scoring CT study was frequently conducted prior to a cCTA exam. With the new generation of CT scanners, CS can be accomplished from cCTA; a separate CS study, which increases the patient’s radiation exposure, has the potential to be avoided. The feasibility of this approach has been demonstrated by a number of studies using semi-automatic segmentation of calcified lesions. Rcadia is developing a system based on a fully automatic approach designed to bring simplicity and consistency into this technique.
To evaluate the diagnostic performance of the system, a retrospective trial was conducted based on cCTA and standard calcium scoring studies of 215 patients. Calcium score automatically computed from cCTA by Rcadia’s software was compared to the Agatston score obtained from nonenhanced calcium scoring studies using the standard technique. The system demonstrated good correlation with the standard Agatston score, achieving 90% accuracy for the classification into five calcium score ranges (0, 1-10, 11-100, 101-400, and above 400). The company believes the trial is the first reported study to match an automatically computed calcium score from cCTA to the standard Agatston score from non-enhanced calcium scoring studies.
“The promising results of this first trial suggest that automatic calcium score assessment has potential to increase the value of the cCTA exam,” said Shai Levanon, president and CEO of Rcadia. “The software will be optimized and validated in future studies.” He noted, “The calcium scoring application is in line with the company’s vision of providing a comprehensive analysis of coronary arteries, including quantitative assessment of the total coronary plaque burden and introduction of an alternative to calcium score with better predictive value.”
Rcadia Medical Imaging, Ltd. develops and markets proprietary computerized systems that automatically detect clinical abnormalities in digital medical images, particularly for patient triage in emergency, life-threatening conditions. The company’s first US Food and Drug Administration (FDA)-cleared product, the COR analyzer system, provides fully automated, real-time analysis of coronary CT angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR analyzer improves the utility of coronary CTA studies in the emergency department to triage chest pain patients and optimizes workflow in cardiology and radiology departments.
Related Links:
Rcadia Medical Imaging
This work in progress is based on Rcadia Medical Imaging (Newton, MA, USA) COR analyzer system technology for fully automatic detection of stenosis in cCTA studies.
CS is an important predictor of coronary artery disease that is typically used by cardiologists. Until recently, a separate calcium scoring CT study was frequently conducted prior to a cCTA exam. With the new generation of CT scanners, CS can be accomplished from cCTA; a separate CS study, which increases the patient’s radiation exposure, has the potential to be avoided. The feasibility of this approach has been demonstrated by a number of studies using semi-automatic segmentation of calcified lesions. Rcadia is developing a system based on a fully automatic approach designed to bring simplicity and consistency into this technique.
To evaluate the diagnostic performance of the system, a retrospective trial was conducted based on cCTA and standard calcium scoring studies of 215 patients. Calcium score automatically computed from cCTA by Rcadia’s software was compared to the Agatston score obtained from nonenhanced calcium scoring studies using the standard technique. The system demonstrated good correlation with the standard Agatston score, achieving 90% accuracy for the classification into five calcium score ranges (0, 1-10, 11-100, 101-400, and above 400). The company believes the trial is the first reported study to match an automatically computed calcium score from cCTA to the standard Agatston score from non-enhanced calcium scoring studies.
“The promising results of this first trial suggest that automatic calcium score assessment has potential to increase the value of the cCTA exam,” said Shai Levanon, president and CEO of Rcadia. “The software will be optimized and validated in future studies.” He noted, “The calcium scoring application is in line with the company’s vision of providing a comprehensive analysis of coronary arteries, including quantitative assessment of the total coronary plaque burden and introduction of an alternative to calcium score with better predictive value.”
Rcadia Medical Imaging, Ltd. develops and markets proprietary computerized systems that automatically detect clinical abnormalities in digital medical images, particularly for patient triage in emergency, life-threatening conditions. The company’s first US Food and Drug Administration (FDA)-cleared product, the COR analyzer system, provides fully automated, real-time analysis of coronary CT angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR analyzer improves the utility of coronary CTA studies in the emergency department to triage chest pain patients and optimizes workflow in cardiology and radiology departments.
Related Links:
Rcadia Medical Imaging
Latest Radiography News
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
- Advanced 3D Mammography Detects More Breast Cancers
Channels
MRI
view channel
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read more
First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
Each year, approximately 800,000 people in the U.S. experience strokes, with marginalized and minoritized groups being disproportionately affected. Strokes vary in terms of size and location within the... Read moreUltrasound
view channel
Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more
High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
Each year, approximately one million prostate cancer biopsies are conducted across Europe, with similar numbers in the USA and around 100,000 in Canada. Most of these biopsies are performed using MRI images... Read more
World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
Ultrasound devices play a vital role in the medical field, routinely used to examine the body's internal tissues and structures. While advancements have steadily improved ultrasound image quality and processing... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read more
Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
Lung infections can be life-threatening for patients with weakened immune systems, making timely diagnosis crucial. While CT scans are considered the gold standard for detecting pneumonia, repeated scans... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more